Already in early stages of CKD, patients with higher concentrations of FGF23 face an increased risk of all‐cause mortality and of progression to ESRD compared to patients with lower FGF23 concentrations (Isakova et al. The gene discussed is FGF23; the disease is chronic kidney disease.